Mediclinic International Plc (MDC) 2017年年度报告「LSE」.pdf

1、MEDICLINIC|ANNUAL REPORT AND FINANCIAL STATEMENTS 2017ANNUAL REPORTAND FINANCIALSTATEMENTSfor the year ended 31 March REPORT PROFILESCOPE,BOUNDARY AND REPORTING CYCLEThis Annual Report and Financial Statements(“Annual Report”)of Mediclinic International plc(the“Company”or“Mediclinic”)presents the fi

2、nancial results,and the economic,social and environmental performance of the Mediclinic Group for the financial year ended 31 March 2017(the“reporting period”),and covers the Companys operations in Southern Africa,Switzerland and the United Arab Emirates(the“Group”).REPORTING PRINCIPLESThe informati

3、on in this Annual Report is deemed to be useful and relevant to our stakeholders,with due regard to our stakeholders expectations through continuous engagement,or that the Board believes may influence the perception or decision-making of our stakeholders.The information provided aims to provide our

4、stakeholders with an understanding of the Groups financial,social,environmental and economic impacts to enable them to evaluate the ability of Mediclinic to create and sustain value for our stakeholders.This Annual Report was prepared in accordance with the International Financial Reporting Standard

5、s,the LSE Listing Rules,the JSE Listings Requirements,the UK Corporate Governance Code,and the UK Companies Act(including the recently promulgated Companies,Partnerships and Group(Accounts and Non-Financial Reporting)Regulations 2016)aimed at improving the transparency of companies regarding non-fin

6、ancial and diversity information,where relevant.The Company applied the majority of the principles contained in the UK Corporate Governance Code.Principles not applied are explained in the Corporate Governance Statement,included in this Annual Report.The Companys reporting on sustainable development